Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Subject: Heart Disease - PUBLISHED VIA Author Manuscript
Author(s):
Rajesh M, Mukhopadhyay P, Bátkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horváth B, Mukhopadhyay B, Becker L, Haskó G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P
View Source >>
Related Studies:
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury.
Published via American Journal of Physiology
The effect of cannabidiol on ischemia/reperfusion-induced ventricular arrhythmias: the role of adenosine A1 receptors.
Published via Journal of Cardiovascular Pharmacology and Therapeutics
Is the cardiovascular system a therapeutic target for cannabidiol?
Published via British Pharmacological Society
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion.
Published via British Journal of Pharmacology
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors
Published via BMJ Publishing Group Limited